REFERENCES

The complete list of references can be found at www.expertconsult.com.

REFERENCES

1. Holmgren N, Valberg S: Measurement of serum myoglobin concentrations in horses by immunodiffusion, Am J Vet Res 53:957, 1992.

2. Rasanen LA: Exercise-induced purine nucleotide degradation and changes in myocellular protein release, Equine Vet J Suppl 18:235, 1995.

3. Harris PA, Snow DH: Role of electrolyte imbalances in the pathophysiology of the equine rhabdomyolysis syndrome. In Persson S, Lindholm A, Jeffcott LB, editors: Equine exercise physiology, ed 3, Davis, CA, 1991, ICEEP Publications, pp 435-442.

4. McKenzie EC, Valberg SJ, Godden SM, et al: Comparison of volumetric urine collection versus single-sample urine collection in horses consuming diets varying in cation-anion balance, Am J Vet Res 64:284, 2003.

5. McKenzie EC, Valberg SJ, Godden SM, et al: Plasma and urine electrolyte and mineral concentrations in thoroughbred horses with recurrent exertional rhabdomyolysis after consumption of diets varying in cation­anion balance, Am J Vet Res 63:1053, 2002.

6. Valberg S, Jonsson L, Lindholm A, et al: Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis, Equine Vet J 25:11, 1993.

7. Valberg SJ, Mickelson JR, Gallant EM, et al: Exertional rhabdomyolysis in quarter horses and thoroughbreds: one syndrome, multiple aetiologies, Equine Vet J Suppl 30:533, 1999.

8. Valberg SJ, MacLeay JM, Mickelson JR: Polysaccharide storage myopathy associated with exertional rhabdomyolysis in horses, Comp Cont Educ Pract Vet 19:1077, 1997.

9. Wijnberg ID, van der Kolk JH, Franssen H, et al: Needle electromyography in the horse compared with its principles in man: a review, Equine Vet J 35:9, 2003.

10. Wijnberg ID, Franssen H, Jansen GH, et al: Quantitative electromyo­graphic examination in myogenic disorders of 6 horses, J Vet Intern Med 17:185, 2003.

11. Wijnberg ID, Franssent H, van der Kolk JH, et al: Quantitative motor unit action potential analysis of skeletal muscles in the warmblood horse, Equine Vet J 34:556, 2002.

12. Wijnberg ID, Back W, de Jong M, et al: The role of electromyography in clinical diagnosis of neuromuscular locomotor problems in the horse, Equine Vet J 36:718, 2004.

13. Andrews FM, Fenner WR: Indication and use of electrodiagnostic aids in neurologic disease, Vet Clin North Am Equine Pract 3:293, 1987.

14. Valberg SJ, Dyson S: Skeletal muscle and lameness. In Ross M, Dyson S, editors: Lameness in the horse, ed 1, Philadelphia, PA, 2003, Saunders, pp 723-743.

15. Morris E, Seeherman HJ, O’Callaghan MW, et al: Scintigraphic identifica­tion of skeletal muscle damage in horses 24 hours after strenuous exercise, Equine Vet J 23:347, 1991.

16. Cumming WJK, Fulthorpe JJ, Hudgson P, et al: Color atlas of muscle pathology, ed 1, London, 1994, Mosby-Wolfe.

17. Cardinet GH, III, Holliday TA: Neuromuscular diseases of domestic animals: a summary of muscle biopsies from 159 cases, Ann N Y Acad Sci 317:290, 1979.

18. Firshman AM, Valberg SJ, Bender JB, et al: Comparison of histopathologic criteria and skeletal muscle fixation techniques for the diagnosis of polysaccharide storage myopathy in horses, Vet Pathol 43:257, 2006.

19. Lentz LR, Valberg SJ, Balog EM, et al: Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis, Am J Vet Res 60:992, 1999.

20. Hildebrand SV, Arpin D, Cardinet GIII: Contracture test and histologic and histochemical analyses of muscle biopsy specimens from horses with exertional rhabdomyolysis, J Am Vet Med Assoc 196:1077, 1990.

21. Beech J, Lindborg S, Fletcher JE, et al: Caffeine contractures, twitch characteristics and the threshold for ca(2+)-induced ca2+ release in skeletal muscle from horses with chronic intermittent rhabdomyolysis, Res Vet Sci 54:110, 1993.

22. Layzer RB: Muscle pain, cramps and fatigue.

23. Cannon SC, Hayward LJ, Beech J, et al: Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis, J Neurophysiol 73:1892,

1995.

24. Bryant SH, Conte-Camerino D: Chloride channel regulation in the skeletal muscle of normal and myotonic goats, Pflugers Arch 417:605, 1991.

25. Hulland TJ: Muscle and tendons. In Jubb KVF, Kennedy PC, Palmer N, editors: Pathology of domestic animals, ed 3, Orlando, FL, 1985, Academic Press, p 139.

26. Lewis SS, Valberg SJ, Nielsen IL: Suspected immune-mediated myositis in horses, J Vet Intern Med 21:495, 2007.

27. Warren JD, Blumbergs PC, Thompson PD: Rhabdomyolysis: a review, Muscle Nerve 25:332, 2002.

28. Spier SJ, Carlson GP, Holliday TA, et al: Hyperkalemic periodic paralysis in horses, J Am Vet Med Assoc 197:1009, 1990.

29. Reed SM, Hegreberg GA, Bayly WM, et al: Progressive myotonia in foals resembling human dystrophia myotonica, Muscle Nerve 11:291, 1988.

30. Jamison JM, Baird JD, Smith-Maxie LL, et al: A congenital form of myotonia with dystrophic changes in a quarterhorse, Equine Vet J 19:353,

1987.

31. Madigan JE, Valberg SJ, Ragle C, et al: Muscle spasms associated with ear tick (otobius megnini) infestations in five horses, J Am Vet Med Assoc 207:74, 1995.

32. Keith JR: Spastic paresis in beef and dairy cattle, Vet Med Small Anim Clin 76:1043, 1981.

33. Griffiths IB: Spastic paresis in calves, Vet Rec 156:786, 2005.

34. Ledoux JM: Bovine spastic paresis: etiological hypotheses, Med Hypotheses 57:573, 2001.

35. Wijeratine WV: Letter: heritability of spastic paresis, Vet Rec 98:139, 1976.

36. Bourke CA: Bovine asymmetric hind limb paresis, a presumptive in-utero plant poisoning, Aust Vet J 74:42, 1996.

37. Baird JD, Firshman AM, Valberg SJ: Shivers (shivering) in the horse: a review, Proc Am Assoc Equine Pract 52:359, 2006.

38. Aman J, Valberg SJ, Elangovan N, et al: Abnormal locomotor muscle recruitment patterns in horses with shivering and purkinje cell distal axonopathy, Equine Vet J 2018, doi:10.1111/evj.12813.

39. Lehmann-Horn F, Jurkat-Rott K, Rudel R: Periodic paralysis: understanding channelopathies, Curr Neurol Neurosci Rep 2:61, 2002.

40. Lehmann-Horn F, Jurkat-Rott K: Voltage-gated ion channels and hereditary disease, Physiol Rev 79:1317, 1999.

41. Bryant SH, Lipicky RJ, Herzog WH: Variability of myotonic signs in myotonic goats, Am J Vet Res 29:2371, 1968.

42. Schooley EK, MacLeay JM, Cuddon P, et al: Myotonia congenita in a foal, J Equine Vet Science 24:483, 2004.

43. Bryant SH: Myotonia in the goat, Ann N Y Acad Sci 317:314, 1979.

44. Smith MC, Sherman DM: Musculoskeletal system. In Goat medicine, Malvern, PA, 1994, Lea & Febiger, pp 109-110.

45. Wijnberg ID, Owczarek-Lipska M, Sacchetto R, et al: A missense mutation in the skeletal muscle chloride channel 1 (CLCN1) as candidate causal mutation for congenital myotonia in a new forest pony, Neuromuscul Disord 22:361, 2012.

46. Montagna P, Liguori R, Monari L, et al: Equine muscular dystrophy with myotonia, Clin Neurophysiol 112:294, 2001.

47. Day JW, Ranum LP: Genetics and molecular pathogenesis of the myotonic dystrophies, Curr Neurol Neurosci Rep 5:55, 2005.

48. Day JW, Ranum LP: RNA pathogenesis of the myotonic dystrophies, Neuromuscul Disord 15:5, 2005.

49. Beech J, Fletcher JE, Tripolitis L, et al: Effects of phenytoin in two myotonic horses with hyperkalemic periodic paralysis, Muscle Nerve 15:932,

1992.

50. DeLahunta A: Veterinary neuroanatomy and clinical neurology, ed 2, Phila­delphia, PA, 1983, WB Saunders.

51. Hegreberg GA, Reed SM: Skeletal muscle changes associated with equine myotonic dystrophy, Acta Neuropathol (Berl) 80:426, 1990.

52. Meyer TS, Fedde MR, Cox JH, et al: Hyperkalaemic periodic paralysis in horses: a review, Equine Vet J 31:362, 1999.

53. Naylor JM: Equine hyperkalemic periodic paralysis: review and implications, Can Vet J 35:279, 1994.

54. Rudolph JA, Spier SJ, Byrns G, et al: Linkage of hyperkalaemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene, Anim Genet 23:241, 1992.

55. Cox JH: An episodic weakness in four horses associated with intermittent serum hyperkalemia and the similarity of the disease to hyperkalemic periodic paralysis in man, Proceedings of the Annual Convention of the American Association of Equine Practitioners 31:383, 1986.

56. Tryon RC, Penedo MC, McCue ME, et al: Evaluation of allele frequencies of inherited disease genes in subgroups of American quarter horses, J Am Vet Med Assoc 234:120, 2009.

57. Naylor JM: Selection of quarter horses affected with hyperkalemic periodic paralysis by show judges, J Am Vet Med Assoc 204:926, 1994.

58. Groves L: HYPP: someone else’s problem?, Quarter Horse J 1:59, 2007.

59. Reynolds AJ: Equine hyperkalemic periodic paralysis (HYPP): overview and management strategies, 2007. [WWW page]. http://www.admani. com∕horse∕Equine%20Library∕Horse%20Equine%20HYPP.htm, (Accessed 18 November 2013).

60. Carr EA, Spier SJ, Kortz GD, et al: Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis, J Am Vet Med Assoc 209:798, 1996.

61. Naylor JM: Hyperkalemic periodic paralysis, Vet Clin North Am Equine Pract 13:129, 1997.

62. Pickar JG, Spier SJ, Snyder JR, et al: Altered ionic permeability in skeletal muscle from horses with hyperkalemic periodic paralysis, Am J Physiol 260(5 Pt 1):C926, 1991.

63. Reynolds JA, Potter GD, Greene LW: Genetic-diet interactions in the hyperkalemic periodic paralysis syndrome in quarter horses fed varying amounts of potassium, III. The relationship between plasma potassium concentration and HYPP symptoms, J Equine Vet Sci 18:731, 1998.

64. Ott EA: National research council: nutrient requirements of horses, Washington, DC, 2007, The National Academies Press.

65. Zhou J, Spier SJ, Beech J, et al: Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis, Hum Mol Genet 3:1599, 1994.

66. Diakakis K, Spanoudes K, Dessiris A: Hyperkalaemic periodic paralysis­like syndrome in a criollo argentino horse, Equine vet Educ 20(8):396,

2008.

67. Peek SF, Divers TJ, Guard C, et al: Hypokalemia, muscle weakness, and recumbency in dairy cattle, Vet Ther 1:235, 2000.

68. Michell AR: Hypokalaemia in cattle, Vet Rec 143:540, 1998.

69. Sattler N, Fecteau G, Girard C, et al: Description of 14 cases of bovine hypokalaemia syndrome, Vet Rec 143:503, 1998.

70. Sieb JP, Penn AS: Myoglobinuria. In Engel AG, Franzini-Armstrong C, editors: Myology, ed 3, NY, 2004, McGraw-Hill, New York, pp 1677-1692.

71. Carlson GP: 1985. Medical problems associated with protracted heat and work stress in horses. #84. Proceedings of the Fifth Annual Association of Equine Sports Medicine, Feb 27, Reno, NV.

72. Foreman JH: The exhausted horse syndrome, Vet Clin North Am Equine Pract 14:205, 1998.

73. McCutcheon LJ, Geor RJ: Sweating, fluid and ion losses and replacement, Vet Clin North Am Equine Pract 14:75, 1998.

74. McCutcheon LJ, Geor RJ, Hare MJ, et al: Sweating rate and sweat composition during exercise and recovery in ambient heat and humidity, Equine Vet J Suppl 153:1995.

75. Schott HC, McGlade KS, Molander HA, et al: Body weight, fluid, electrolyte, and hormonal changes in horses competing in 50- and 100-mile endurance rides, Am J Vet Res 58:303, 1997.

76. Schott HC, Hinchcliff KW: Treatments affecting fluid and electrolyte status during exercise, Vet Clin North Am Equine Pract 14:175, 1998.

77. Carlson GP: Synchronous diaphragmatic flutter. In Robinson NE, editor: Current therapy in equine medicine, ed 2, Philadelphia, PA, 1987, WB Saunders, pp 485-486.

78. Mansmann RA, Carlson GP, White NA, et al: Synchronous diaphragmatic flutter in horses, J Am Vet Med Assoc 165:265, 1974.

79. Hudson NP, Church DB, Trevena J, et al: Primary hypoparathyroidism in two horses, Aust Vet J 77:504, 1999.

80. White NA, White SL: Atrioventricular dissociation with synchronous diaphragmatic flutter in a horse, Vet Med Small Anim Clin 70:967, 1975.

81. Brewer BD: Disorders in calcium metabolism. In Robinson NE, editor: Current therapy in equine medicine, ed 2, Philadelphia, PA, 1987, WB Saunders, pp 189-192.

82. Baird JD: Lactation tetany (eclampsia) in a shetland pony mare, Aust Vet J 47:402, 1971.

83. Durie I, van Loon G, Hesta M, et al: Hypocalcemia caused by primary hypoparathyroidism in a 3-month-old filly, J Vet Intern Med 24:439, 2010.

84. Grubb TL, Foreman JH, Benson GJ, et al: Hemodynamic effects of calcium gluconate administered to conscious horses, J Vet Intern Med 10:401, 1996.

85. Erwin BG: Clostridial bacteria and clostridial myositis. In Berg JN, editor: Current veterinary therapy (food animal practice), ed 2, Philadelphia, PA, 1986, WB Saunders, pp 567-570.

86. Blood DC, Radostis OM, Henderson JA: Veterinary medicine, ed 6, London, 1983, Bailliere Tindall.

87. Peek SF, Semrad SD, Perkins GA: Clostridial myonecrosis in horses (37 cases 1985-2000), Equine Vet J 35:86, 2003.

88. Williams BM: Clostridial myositis in cattle: bacteriology and gross pathology, Vet Rec 100:90, 1977.

89. Rebhun WC, Shin SJ, King JM, et al: Malignant edema in horses, J Am Vet Med Assoc 187:732, 1985.

90. Vengust M, Arroyo LG, Weese JS, et al: Preliminary evidence for dormant clostridial spores in equine skeletal muscle, Equine Vet J 35:514, 2003.

91. Slack JA, McGuirk SM, Erb HN, et al: Biochemical markers of cardiac injury in normal, surviving septic, or nonsurviving septic neonatal foals, J Vet Intern Med 19:577, 2005.

92. Sponseller BT, Valberg SJ, Tennent-Brown BS, et al: Severe acute rhabdomyolysis associated with streptococcus equi infection in four horses, J Am Vet Med Assoc 227:1800, 2005.

93. Valberg SJ, Bullock P, Hogetvedt W, et al: Myopathies associated with streptococcus equi infections in horses, Proc Am Assoc Equine Pract 292-293,

1996.

94. Sweeney CR, Timoney JF, Newton JR, et al: Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles, J Vet Intern Med 19:123, 2005.

95. Al-Ghamdi GM, Kapur V Ames TR, et al: Use of repetitive sequence-based polymerase chain reaction for molecular epidemiologic analysis of streptococcus equi subspecies equi, Am J Vet Res 61:699, 2000.

96. Adams EM, Gudmundsson S, Yocum DE, et al: Streptococcal myositis, Arch Intern Med 145(1020):1985, 1985.

97. Pusterla N, Watson JL, Affolter VK, et al: Purpura haemorrhagica in 53 horses, Vet Rec 153:118, 2003.

98. Kaese HJ, Valberg SJ, Hayden DW, et al: Infarctive purpura hemorrhagica in five horses, J Am Vet Med Assoc 226(1893):1845, 2005.

99. Galan JE, Timoney JF: Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of streptococcus equi, J Immunol 135:3134, 1985.

100. Barrott MJ, Brooks HW, McGowan CM: Suspected immune-mediated myositis in a pony, Equine Vet Educ April:80, 2004.

101. Valberg SJ: Spinal muscle pathology, Vet Clin North Am Equine Pract 15:87, 1999.

102. Hunyadi L, Sundman EA, Kass PH, et al: J Vet Intern Med 31:170, 2017.

103. Durward-Akhurst SA, Finno CJ, Barnes N, et al: J Vet Intern Med 30:1313, 2016.

104. Finno CJ, Perumbakkam S, Williams Z, et al. Skeletal Muscle (in press), 2018.

105. Durward-Akhurst SA, Valberg SJ: Vet Pathol 55(1):68, 2018.

106. Pasolini MP, Pagano TB, Costagliola A, et al: Vet Pathol 55(1):133, 2018.

107. Barrott MJ, Brooks HW, McGowan CM: Suspected immune-mediated myositis in a pony, Equine Vet Educ 80:2004.

108. Harris PA: An outbreak of the equine rhabdomyolysis syndrome in a racing yard, Vet Rec 127:468, 1990.

109. Freestone JF, Carlson GR: Muscle disorders in the horse: a retrospective study, Equine Vet J 23:86, 1991.

110. Dubey JP, Fayer R: Sarcocystosis, toxoplasmosis, and cryptosporidiosis in cattle, Vet Clin North Am Food Anim Pract 2:293, 1986.

111. Fayer R, Elsasser TH: Bovine sarcocystosis: how parasites negatively affect growth, Parasitol Today 7:250, 1991.

112. Fayer R, Dubey JP: Development of sarcocystis fayeri in the equine, J Parasitol 68:856, 1982.

113. Aleman M, Shapiro K, Siso S, et al: Sarcocystis fayeri in skeletal muscle of horses with neuromuscular disease, Neuromuscul Disord 26(1):85, 2016.

114. Fayer R, Johnson AJ: Effect of amprolium on acute sarcocystosis in experimentally infected calves, J Parasitol 61:932, 1975.

115. McMurray CH, Rice DA: Vitamin E and selenium deficiency diseases, Irish Vet J 36:57, 1982.

116. Dill SG, Rebhun WC: White muscle disease in foals, Comp Cont Educ Pract Vet 7:S627, 1985.

117. Maylin GA, Rubin DS, Lein DH: Selenium and vitamin E in horses, Cornell Vet 70:272, 1980.

118. Perkins G, Valberg SJ, Madigan JM, et al: Electrolyte disturbances in foals with severe rhabdomyolysis, J Vet Intern Med 12:173, 1998.

119. Maas J, Galey FD, Peauroi JR, et al: The correlation between serum selenium and blood selenium in cattle, J Vet Diagn Invest 4:48, 1992.

120. Taylor RF, Puls R, MacDonald KR: Bovine abortions associated with selenium deficiency in western Canada, Proc Amer Assoc Vet Lab Diagnosti­cians 77-94, 1979.

121. Moncada S, Vane JR: Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls, N Engl J Med 300:1142, 1979.

122. Burk RF, Hill KE: Regulation of selenoproteins, Annu Rev Nutr 13:65,

1993.

123. Campbell DT, Maas J, Weber DW, et al: Safety and efficacy of two sustained-release intrareticular selenium supplements and the associated placental and colostral transfer of selenium in beef cattle, Am J Vet Res 51:813, 1990.

124. Koller LD, Whitbeck GA, South PJ: Transplacental transfer and colostral concentrations of selenium in beef cattle, Am J Vet Res 45:2507, 1984.

125. Roneus B, Lindholm A: Glutathione peroxidase activity in the blood of healthy horses given different selenium supplementation, Nord Vet Med 35:337, 1983.

126. Maas J, Peauroi JR, Tonjes T, et al: Intramuscular selenium administration in selenium-deficient cattle, J Vet Intern Med 7:342, 1993.

127. Roneus B: Glutathione peroxidase and selenium in the blood of healthy horses and foals affected by muscular dystrophy, Nord Vet Med 34:350, 1982.

128. Aharonson-Raz K, Milgram J, Chai O, et al: Fibrosis of the masseter leading to trismus and dysphagia in a mare, Vet Rec 164:597, 2009.

129. Pearson EG, Snyder SP, Saulez MN: Masseter myodegeneration as a cause of trismus or dysphagia in adult horses, Vet Rec 156:642, 2005.

130. Step DL, Divers TJ, Cooper B, et al: Severe masseter myonecrosis in a horse, J Am Vet Med Assoc 198:117, 1991.

131. Pearson EG, Snyder SP, Saulez MN: Masseter myodegeneration as a cause of trismus or dysphagia in adult horses, Vet Rec 156(20):642, 2005.

132. Eckert J, Ossent P: Haycocknema-like nematodes in muscle fibres of a horse, Vet Parasitol 139:256, 2006.

133. Bedford HE, Valberg SJ, Firshman AM, et al: Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E-responsive muscle atrophy and weakness, J Am Vet Med Assoc 242:1127, 2013.

134. Elanco Products: Safety and toxicity. In Elanco technical manual, ed 2, Indianapolis, IN, 1980, Elanco Products, pp H1-H16.

135. Miller RE, Boever WJ, Junge RE, et al: Acute monensin toxicosis in stone sheep (ovis dalli stonei), blesbok (damaliscus dorcus phillipsi), and a bactrian camel (camelus bactrianus), J Am Vet Med Assoc 196:131, 1990.

136. Benson JE, Ensley SM, Carson TL, et al: Lasalocid toxicosis in neonatal calves, J Vet Diagn Invest 10:210, 1998.

137. Helman RG, Edwards WC: Clinical features of blister beetle poisoning in equids: 70 cases (1983-1996), J Am Vet Med Assoc 211:1018, 1997.

138. Inns RH, Tuckwell NJ, Bright JE, et al: Histochemical demonstration of calcium accumulation in muscle fibres after experimental organophos­phate poisoning, Hum Exp Toxicol 9:245, 1990.

139. Karalliedde L, Baker D, Marrs TC: Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy, Toxicol Rev 25:1, 2006.

140. Cavaliere MJ, Calore EE, Perez NM, et al: Organophosphate-induced myotoxicity], Rev Saude Publica 30:267, 1996.

141. Myers CJ, Aleman M, Heidmann R, et al: Myopathy in American miniature horses, Equine Vet J 38:272, 2006.

142. Putnam MR, Boosinger T, Spano J, et al: Evaluation of cassia obtusifolia (sicklepod) seed consumption in holstein calves, Vet Hum Toxicol 30:316,

1988.

143. Beier RC, Norman JO, Irvin TR, et al: Microsomal activation of con­stituents of white snakeroot (eupatorium rugosum houtt) to form toxic products, Am J Vet Res 48:583, 1987.

144. Beier RC, Norman JO: The toxic factor in white snakeroot: identity, analysis and prevention, Vet Hum Toxicol 32(Suppl):81, 1990.

145. Thompson LJ: Depression and choke in a horse: probable white snakeroot toxicosis, Vet Hum Toxicol 31:321, 1989.

146. Bauquier J, Stent A, Gibney J, et al: Evidence for marsh mallow (malva parviflora) toxicosis causing myocardial disease and myopathy in four horses, Equme Vet J 49(3):307, 2017.

147. Finno CJ, Valberg SJ, Wunschmann A, et al: Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998-2005), J Am Vet Med Assoc 229:1134, 2006.

148. Hillam RA: Atypical myoglobinuria, Vet Rec 128:166, 1991.

149. Whitwell KE, Harris P, Farrington PG: Atypical myoglobinuria: an acute myopathy in grazing horses, Equine Vet J 20:357, 1988.

150. Cassart D, Baise E, Cherel Y, et al: Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy, Equme Vet J 39:26, 2007.

151. Gerber V, Straub R, Frey J: Equine botulism and acute pasture myodys­trophy: new soil-borne emerging diseases in Switzerland?, Schweiz Arch Tierheilkd 148:553, 2006.

152. Van Galen G, Marcillaud PC, Saegerman C, et al: European outbreaks of atypical myopathy in grazing equids (2006-2009): spatiotemporal distribution, history and clinical features, Equine Vet J 44:614, 2012.

153. Van Galen G, Saegerman C, Marcillaud PC, et al: European outbreaks of atypical myopathy in grazing horses (2006-2009): determination of indicators for risk and prognostic factors, Equine Vet J 44:621, 2012.

154. Van Galen G, Cerri S, Porter S, et al: Traditional and quantitative assess­ment of acid-base and shock variables in horses with atypical myopathy, J Vet Intern Med 27:186, 2013.

155. Westermann CM, Dorland L, Votion DM, et al: Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy, Neuromuscul Disord 18:355, 2008.

156. Sponseller BT, Valberg SJ, Schultz NE, et al: Equine multiple acyl-CoA dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the midwestern United States, J Vet Intern Med 26:1012, 2012.

157. Valberg SJ, Sponseller BT, Hegeman AD, et al: Seasonal pasture myopathy/ atypical myopathy in north America associated with ingestion of hypoglycin A within seeds of the box elder tree, Equine Vet J 45:419, 2013.

158. Bochnia M, Ziegler J, Sander J, et al: Hypoglycin A content in blood and urine discriminates horses with atypical myopathy from clinically normal horses grazing on the same pasture, PLoS ONE 10(9):e0136785, 2015.

159. Westermann CM, van Leeuwen R, van Raamsdonk LW, et al: Hypoglycin A concentrations in maple tree species in the Netherlands and the occurrence of atypical myopathy in horses, J Vet Intern Med 30(3):880-884, 2016.

160. Rebhun WC: Diseases of dairy cattle, ed 1, Media, PA, 1995, Williams & Wilkins.

161. Richey MT, Holland MS, McGrath CJ, et al: Equine post-anesthetic lameness. A retrospective study, Vet Surg 19:392, 1990.

162. White NAI: Postanesthetic recumbency myopathy in horses, Compend Cont Educ 4:544, 1982.

163. Hennig GE, Court MH: Equine postanesthetic myopathy: an update, Compend Cont Educ 13:1709, 1991.

164. Norman WM, Williams R, Dodman NH, et al: Postanesthetic compart­mental syndrome in a horse, J Am Vet Med Assoc 195:502, 1989.

165. Branson KR: The hemodynamic, tissue oxygenation and selected biochemi­cal effects of isoflurane and halothane anesthesia in horses, J Equine Vet Sci 7:396, 1993.

166. Grandy JL, Steffey EP, Hodgson DS, et al: Arterial hypotension and the development of postanesthetic myopathy in halothane-anesthetized horses, Am J Vet Res 48:192, 1987.

167. Duke T, Filzek U, Read MR, et al: Clinical observations surrounding an increased incidence of postanesthetic myopathy in halothane-anesthetized horses, Vet Anaesth Analg 33:122, 2006.

168. McKenzie EC, Valberg SJ, Godden SM, et al: Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis, Am J Vet Res 65:74, 2004.

169. Hildebrand SV, Howitt GA: Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane, Am J Vet Res 44:2280, 1983.

170. Manley SV, Kelly AB, Hodgson D: Malignant hyperthermia-like reactions in three anesthetized horses, J Am Vet Med Assoc 183:85, 1983.

171. Ward TL, Valberg SJ, Gallant EM, et al: Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis, Am J Vet Res 61:242, 2000.

172. Mickelson JR, Gallant EM, Litterer LA, et al: Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia, J Biol Chem 263:9310, 1988.

173. Aleman M, Brosnan RJ, Williams DC, et al: Malignant hyperthermia in a horse anesthetized with halothane, J Vet Intern Med 19:363, 2005.

174. Aleman M, Riehl J, Aldridge BM, et al: Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia, Muscle Nerve 30:356, 2004.

175. Bloom BA, Valentine BA, Gleed RD, et al: Postanaesthetic recumbency in a belgian filly with polysaccharide storage myopathy, Vet Rec 144:73,

1999.

176. Klein L, Ailes N, Fackelman GE, et al: Postanesthetic equine myopathy suggestive of malignant hyperthermia. A case report, Vet Surg 18:479,

1989.

177. Valverde A, Boyd CJ, Dyson DH, et al: Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse, J Am Vet Med Assoc 197:1051, 1990.

178. Hawkins DL: The thigh. In Ross M, Dyson SJ, editors: Lameness in the horse, ed 2, St Louis, MO, 2011, Elsevier, Saunders, pp 550-552.

179. Bishop R: Fibrotic myopathy in the gracilis muscle of a horse, Vet Med Small Anim Clin 67:270, 1972.

180. Dabareiner RM, Schmitz DG, Honnas CM, et al: Gracilis muscle injury as a cause of lameness in two horses, J Am Vet Med Assoc 224:1630, 2004.

181. Gomez-Villamandos R, Santisteban J, Ruiz I, et al: Tenotomy of the tibial insertion of the semitendinosus muscle of two horses with fibrotic myopathy, Vet Rec 136:67, 1995.

182. Irwin DH, Howell DW: Fibrotic myopathy, haematomas and scar tissue in the gaskin area of the thoroughbred, J S Afr Vet Assoc 52:65, 1981.

183. Turner AS, Trotter GW: Fibrotic myopathy in the horse, J Am Vet Med Assoc 184:335, 1984.

184. Cole FL, Mellor DJ, Hodgson DR, et al: Prevalence and demographic characteristics of exertional rhabdomyolysis in horses in Australia, Vet Rec 155:625, 2004.

185. Harris PA: The equine rhabdomyolysis syndrome in the United Kingdom: epidemiological and clinical descriptive information, Br Vet J 147:373, 1991.

186. Harris PA, Snow DH, Greet TR, et al: Some factors influencing plasma AST/CK activities in thoroughbred racehorses, Equine Vet J Suppl 66:1990.

187. McGowan CM, Fordham T, Christley RM: Incidence and risk factors for exertional rhabdomyolysis in thoroughbred racehorses in the United Kingdom, Vet Rec 151:623, 2002.

188. McGowan CM, Posner RE, Christley RM: Incidence of exertional rhabdomyolysis in polo horses in the USA and the United Kingdom in the 1999/2000 season, Vet Rec 150:535, 2002.

189. Firshman AM, Valberg SJ, Bender JB, et al: Epidemiologic characteristics and management of polysaccharide storage myopathy in quarter horses, Am J Vet Res 64:1319, 2003.

190. Dranchak PK, Valberg SJ, Onan GW, et al: Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds, J Am Vet Med Assoc 227:762, 2005.

191. Grobler LA, Collins M, Lambert MI, et al: Skeletal muscle pathology in endurance athletes with acquired training intolerance, Br J Sports Med 38:697, 2004.

192. Valentine BA, Van Saun RJ, Thompson KN, et al: Role of dietary car­bohydrate and fat in horses with equine polysaccharide storage myopathy, J Am Vet Med Assoc 219:1537, 2001.

193. Valentine BA, Hintz HF, Freels KM, et al: Dietary control of exertional rhabdomyolysis in horses, J Am Vet Med Assoc 212:1588, 1998.

194. Harris P, Colles C: The use of creatinine clearance ratios in the prevention of equine rhabdomyolysis: a report of four cases, Equine Vet J 20:459, 1988.

195. Beech J, Lindborg S, Braund KG: Potassium concentrations in muscle, plasma and erythrocytes and urinary fractional excretion in normal horses and those with chronic intermittent exercise-associated rhabdomyolysis, Res Vet Sci 55:43, 1993.

196. Valberg SJ: Diseases of muscle. In Smith BP, editor: Large animal internal medicine, ed 3, St Louis, MO, 2002, Mosby, pp 1272-1273.

197. Roneus B, Hakkarainen J: Vitamin E in serum and skeletal muscle tissue and blood glutathione peroxidase activity from horses with the azoturia- tying-up syndrome, Acta Vet Scand 26:425, 1985.

198. Valberg SJ, Cardinet GH, III, Carlson GP, et al: Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses, Neuromuscul Disord 2:351, 1992.

199. Arighi M, Hulland TJ: Equine exertional rhabdomyolysis, Compend Cont Educ 1:S726, 1984.

200. Andrews FM, Spurgeon TL, Reed SM: Histochemical changes in skeletal muscles of four male horses with neuromuscular disease, Am J Vet Res 47:2078, 1986.

201. Valentine BA, Credille KM, Lavoie JP, et al: Severe polysaccharide storage myopathy in belgian and percheron draught horses, Equine Vet J 29:220,

1997.

202. Valberg SJ, MacLeay JM, Billstrom JA, et al: Skeletal muscle metabolic response to exercise in horses with “tying-up” due to polysaccharide storage myopathy, Equine Vet J 31:43, 1999.

203. Valentine BA, McDonough SP, Chang YF, et al: Polysaccharide storage myopathy in morgan, Arabian, and standardbred related horses and Welsh-cross ponies, Vet Pathol 37:193, 2000.

204. Valentine BA, Cooper BJ: Incidence of polysaccharide storage myopathy: necropsy study of 225 horses, Vet Pathol 42:823, 2005.

205. McCue ME, Valberg SJ, Miller MB, et al: Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis, Genomics 91:458, 2008.

206. McCue ME, Valberg SJ, Lucio M, et al: Glycogen synthase 1 (GYS1) mutation in diverse breeds with polysaccharide storage myopathy, J Vet Intern Med 22:1228, 2008.

207. McCue ME, Armien AG, Lucio M, et al: Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses, Vet Pathol 46:1281, 2009.

208. Carlstrom B: Uber die atiologie und pathogenese der kreuzlahme des pferdes (haemaglobinaemia paralytica), Scand Archiv 62:1, 1932.

209. Annandale EJ, Valberg SJ, Essen-Gustavsson B: Effects of submaximal exercise on adenine nucleotide concentrations in skeletal muscle fibers of horses with polysaccharide storage myopathy, Am J Vet Res 66:839, 2005.

210. Baird JD, Valberg SJ, Anderson SM, et al: Presence of the glycogen synthase 1 (GYS1) mutation causing type 1 polysaccharide storage myopathy in continental European draught horse breeds, Vet Rec 167:781, 2010.

211. McCue ME, Anderson SM, Valberg SJ, et al: Estimated prevalence of the type 1 polysaccharide storage myopathy mutation in selected north American and European breeds, Anim Genet 41(Suppl 2):145, 2010.

212. Stanley RL, McCue ME, Valberg SJ, et al: A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds, Equine Vet J 41:597,

2009.

213. McCue ME, Valberg SJ: Estimated prevalence of polysaccharide storage myopathy among overtly healthy quarter horses in the United States, Am J Vet Res 231:746, 2007.

214. McCue ME, Ribeiro WP, Valberg SJ: Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders, Equine Vet J Suppl 36:340, 2006.

215. Isgren CM, Upjohn MM, Fernandez-Fuente M, et al: Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance, PLoS ONE 5:e11594, 2010.

216. Firshman AM, Baird JD, Valberg SJ: Prevalence and clinical signs of polysaccharide storage myopathy and shivers in belgian draft horses, J Am Vet Med Assoc 227:1958, 2005.

217. Johlig L, Valberg SJ, Mickelson JR, et al: Epidemiological and genetic study of exertional rhabdomyolysis in a warmblood horse family in Switzerland, Equine Vet J 43:240, 2011.

218. Ribeiro WP, Valberg SJ, Pagan JD, et al: The effect of varying dietary starch and fat content on serum creatine kinase activity and substrate availability in equine polysaccharide storage myopathy, J Vet Intern Med 18:887, 2004.

219. McCue ME, Valberg SJ, Jackson M, et al: Polysaccharide storage myopathy phenotype in quarter Horse-related breeds is modified by the presence of an RYR1 mutation, Neuromusc Disorders 19:37, 2008.

220. Borgia L, Valberg S, McCue M, et al: Glycaemic and insulinaemic responses to feeding hay with different non-structural carbohydrate content in control and polysaccharide storage myopathy-affected horses, J Anim Physiol Anim Nutr (Berl) 95:798, 2010.

221. McGowan CM, McGowan TW, Patterson-Kane JC: Prevalence of equine polysaccharide storage myopathy and other myopathies in two equine populations in the United Kingdom, Vet J 180:330, 2009.

222. Byrne E, Jones SL, Valberg SJ, et al: Rhabdomyolysis in two foals with polysaccharide storage myopathy and concurrent pneumonia, Comp Cont Educ Pract Vet 22:503, 2000.

223. Lewis SS, Nicholson AM, Williams Z, et al: Warmblood horses with polysaccharide storage myopathy: clinical characteristics and muscle glycogen concentrations, Am J Vet Res 78(11):1305, 2017.

224. De La Corte FD, Valberg SJ, MacLeay JM, et al: Developmental onset of polysaccharide storage myopathy in 4 quarter horse foals, J Vet Intern Med 16:581, 2002.

225. Sprayberry KA, Madigan J, Lecouteur RA, et al: Renal failure, laminitis, and colitis following severe rhabdomyolysis in a draft horse-cross with polysaccharide storage myopathy, Can Vet J 39:500, 1998.

226. McGowan CM, Menzies-Gow NJ, McDiarmid AM, et al: Four cases of equine polysaccharide storage myopathy in the United Kingdom, Vet Rec 152:109, 2003.

227. Hunt LM, Valberg SJ, Steffenhagen K, et al: An epidemiological study of myopathies in warmblood horses, Equine Vet J 40:171, 2008.

228. Quiroz-Rothe E, Novales M, Guilera-Tejero E, et al: Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain, Equine Vet J 34:171, 2002.

229. Naylor RJ, Livesey L, Schumacher J, et al: Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1), PLoS ONE 7(7):e42317, 2012. https://doi.org/10.1371/journal.pone.0042317.

230. Saha AK, Laybutt DR, Dean D, et al: Cytosolic citrate and malonyl- CoA regulation in rat muscle in vivo, Am J Physiol 276(6 Pt 1):E1030, 1999.

231. Ruderman NB, Saha AK, Vavvas D, et al: Malonyl-CoA, fuel sensing, and insulin resistance, Am J Physiol Endocrinol Metab 276:E1, 1999.

232. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis, Eur J Biochem 244:1, 1997.

233. Borgia LA, Valberg SJ, McCue ME, et al: Effect of dietary fats with odd or even numbers of carbon atoms on metabolic response and muscle damage with exercise in quarter Horse-type horses with type 1 polysac­charide storage myopathy, Am J Vet Res 71:326, 2010.

234. Aleman M, Lecouteur RA, Nieto JE, et al: Sarcoplasmic masses in equine skeletal muscle, Neuromuscul Disord 15:147, 2005.

235. Valberg SJ, McKenzie EC, Eyrich LV, et al: Suspected myofibrillar myopathy in arabian horses with a history of exertional rhabdomyolysis, Equine Vet J 48:548, 2016.

236. McKenzie EC, Eyricha ME, Valberg SJ: Clinical, histopathological and metabolic responses following exercise in arabian horses with a history of exertional rhabdomyolysis, Vet J 216:196, 2016.

237. Valberg SJ, Nicholson AM, Lewis SS, et al: Clinical and histopathological features of myofibrillar myopathy in warmblood horses, Equine Vet J 49(6):739, 2017.

238. Beech J: Chronic exertional rhabdomyolysis, Vet Clin North Am Equine Pract 13:145, 1997.

239. MacLeay JM, Sorum SA, Valberg SJ, et al: Epidemiologic analysis of factors influencing exertional rhabdomyolysis in thoroughbreds, Am J Vet Res 60:1562, 1999.

240. Valberg S, Haggendal J, Lindholm A: Blood chemistry and skeletal muscle metabolic responses to exercise in horses with recurrent exertional rhabdomyolysis, Equine Vet J 25:17, 1993.

241. MacLeay JM, Valberg SJ, Pagan JD, et al: Effect of ration and exercise on plasma creatine kinase activity and lactate concentration in thoroughbred horses with recurrent exertional rhabdomyolysis, Am J Vet Res 61:1390, 2000.

242. McKenzie EC, Valberg SJ, Godden SM, et al: Effect of dietary starch, fat, and bicarbonate content on exercise responses and serum creatine kinase activity in equine recurrent exertional rhabdomyolysis, J Vet Intern Med 17:693, 2003.

243. MacLeay JM, Sorum SA, Valberg SJ, et al: Epidemiologic analysis of factors influencing exertional rhabdomyolysis in thoroughbreds, Am J Vet Res 60:1562, 1999.

244. Upjohn MM, Archer RM, Christley RM, et al: Incidence and risk factors associated with exertional rhabdomyolysis syndrome in national hunt racehorses in great britain, Vet Rec 156:763, 2005.

245. Lentz LR, Valberg SJ, Herold LV, et al: Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis, Am J Vet Res 63:1724, 2002.

246. Lopez JR, Linares N, Cordovez G, et al: Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis, Pflugers Arch 430:293, 1995.

247. Waldron-Mease E, Klein LV, Rosenberg H, et al: Malignant hyperthermia in a halothane-anesthetized horse, J Am Vet Med Assoc 179:896, 1981.

248. Lentz LR, Valberg SJ, Mickelson JR, et al: In vitro contractile responses and contracture testing of skeletal muscle from quarter horses with exertional rhabdomyolysis, Am J Vet Res 60:684, 1999.

249. Dranchak PK, Valberg SJ, Onan GW, et al: Exclusion of linkage of the RYR1, CACNA1s, and ATP2A1 genes to recurrent exertional rhabdo­myolysis in thoroughbreds, Am J Vet Res 67:1395, 2006.

250. Fraunfelder HC, Rossdale PD, Rickets SW: Changes in serum muscle enzyme levels in associated with training schedules and stages of oestrus cycle in thoroughbred racehorses, Equine Vet J 18:371, 1986.

251. MacLeay JM, Valberg SJ, Sorum SA, et al: Heritability of recurrent exertional rhabdomyolysis in thoroughbred racehorses, Am J Vet Res 60:250, 1999.

252. Fritz KL, McCue ME, Valberg SJ, et al: Genetic mapping of recurrent exertional rhabdomyolysis in a population of north American thorough­breds, Anim Genet 43:730, 2012.

253. Norton EM, Mickelson JR, Binns MM, et al: Heritability of Recurrent Exertional Rhabdomyolysis in Standardbred and Thoroughbred Racehorses Derived From SNP Genotyping Data, J Heredity 107(6):537, 2016.

254. Deleted in review.

255. MacLeay JM, Valberg SJ, Pagan JD, et al: Effect of diet on thoroughbred horses with recurrent exertional rhabdomyolysis performing a standardised exercise test, Equine Vet J Suppl 30:458, 1999.

256. Finno CJ, McKenzie E, Valberg SJ, et al: Effect of fitness on glucose, insulin and cortisol responses to diets varying in starch and fat content in thoroughbred horses with recurrent exertional rhabdomyolysis, Equine Vet J Suppl 38:323, 2010.

257. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al: Exercise induced hormonal and metabolic changes in thoroughbred horses: effects of conditioning and acepromazine, Equine Vet J 23:219, 1991.

258. McKenzie EC, Garrett R, Payton M, et al: Effect of feed restriction on plasma dantrolene concentrations in horses, Equine Vet J 42(Suppl 38):613-617, 2010.

259. Edwards JG, Newtont JR, Ramzan PH, et al: The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the thoroughbred racehorse, Equine Vet J 35:707, 2003.

260. Beech J, Fletcher JE, Lizzo F, et al: Effect of phenytoin on the clinical signs and in vitro muscle twitch characteristics in horses with chronic intermittent rhabdomyolysis and myotonia, Am J Vet Res 49:2130, 1988.

261. Beech J: Treating and preventing chronic intermittent rhabdomyolysis, Vet Med May:458, 1994.

262. Vischer CM, Foreman JH, Constable PD, et al: Hemodynamic effects of thyroidectomy in sedentary horses, Am J Vet Res 60:14, 1999.

263. Waldron-Mease E: Hypothyroidism and myopathy in racing thoroughbreds and standardbreds, J Equine Vet Sci 3:124, 1979.

264. Tiidus PM: Manual massage and recovery of muscle function following exercise: a literature review, J Orthop Sports Phys Ther 25:107, 1997.

265. Weerapong P, Hume PA, Kolt GS: The mechanisms of massage and effects on performance, muscle recovery and injury prevention, Sports Med 35:235, 2005.

266. Zainuddin Z, Newton M, Sacco P, et al: Effects of massage on delayed-onset muscle soreness, swelling, and recovery of muscle function, J Athl Train 40:174, 2005.

267. Valberg SJ, Carlson GP, Cardinet GH, III, et al: Skeletal muscle mito­chondrial myopathy as a cause of exercise intolerance in a horse, Muscle Nerve 17:305, 1994.

268. Wagner ML, Valberg SJ, Ames EG, et al: Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in quarter horse and paint horse populations, J Vet Intern Med 20:1207, 2006.

269. Valberg SJ, Ward TL, Rush B, et al: Glycogen branching enzyme deficiency in quarter horse foals, J Vet Intern Med 15:572, 2001.

270. Ward TL, Valberg SJ, Adelson DL, et al: Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV, Mamm Genome 15:570, 2004.

271. Polle F, Andrews F, Gillon T, et al: Suspected congenital centronuclear myopathy in an Arabian-cross foal, J Vet Intern Med 28(6):1886, 2014.

272. Tsujino S, Shanske S, Valberg SJ, et al: Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle’s disease, Neuromuscul Disord 6:19, 1996.

273. Bilstrom JA, Valberg SJ, Bernoco D, et al: Genetic test for myophos­phorylase deficiency in charolais cattle, Am J Vet Res 59:267, 1998.

274. Angelos S, Valberg SJ, Smith BP, et al: Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in six related charolais cattle, Muscle Nerve 18:736, 1995.

275. Johnstone AC, McSporran KD, KennyJE, et al: Myophosphorylase deficiency (glycogen storage disease type v) in a herd of charolais cattle in New Zealand: confirmation by PCR-RFLP testing, N Z Vet J 52:404, 2004.

276. Tan P, Allen JG, Wilton SD, et al: A splice-site mutation causing ovine McArdle’s disease, Neuromuscul Disord 7:336, 1997.

277. Sacchetto R, Testoni S, Gentile A, et al: A defective SERCA1 protein is responsible for congenital pseudomyotonia in chianina cattle, Vet Pathol 174(2):565, 2009.

278. Walter Grunberg W Sacchetto R, Wijnberg I, et al: Pseudomyotonia, a muscle function disorder associated with an inherited ATP2A1 (SERCA1) defect in a Dutch improved red and white cross-breed calf, Neuromuscul Disord 20(7):467, 2010.

279. Milan D, Jeon J-T, Looft C, et al: A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle, Science 288(5469):1248,

2000.